Carlyle Working on PPD Deal?
August 17, 2011- Share:
The Carlyle Group is reportedly in talks to purchase Pharmaceutical Product Development (NASDAQ: PPDI). Other firms rumored to have been interested in the company include The Blackstone Group, Hellman & Friedman and Kohlberg Kravis Roberts. PPD is a contract research organization that provides drug discovery, development and lifecycle management services. Its stock closed yesterday at $32.28.
- Share:
-
-
-
-